CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells

Major Program
NCI Community Oncology Research Program
Research Group
Community Oncology and Prevention Trials
Gynecologic Oncology Group
Active, not recruiting ID
For more information, see NCT00892866
This research trial studies carbonic anhydrase 9 (CA-IX), p16, proliferative markers, and
human papilloma virus (HPV) in diagnosing cervical lesions in patients with abnormal cervical
cells. Studying biomarkers in abnormal cervical cells may improve the ability to find
cervical lesions and plan effective treatment.
Cytology Specimen Collection Procedure, Laboratory Biomarker Analysis
Atypical Endometrial Hyperplasia, Human Papillomavirus Infection, Stage 0 Cervical Cancer AJCC v7
Shu-Yuan liao

See list of participating sites